9th Annual Southern California Kidney Symposium: Updates on Biologics and Novel Therapeutics for Kidney Diseases

Friday, June 6, 2025, 8:00 AM - 4:00 PM, Aresty Conference Center - USC Health Sciences Campus, Los Angeles, CA

AMA PRA Category 1 Credits™ (6.75 hours), Non-Physician Attendance (6.75 hours)

Pre-registration for this program is now closed. To register after 12pm on June 2, 2025, please do visit the registration desk at the conference on Friday, June 6, 2025 starting at 7:30 am. Thank you!

This is the ninth annual Southern California Kidney Symposium with the theme “Updates on Biologics and Novel Therapeutics for Kidney Diseases.” Invited faculty from USC and several other U.S. academic institutions will present in person or virtually before a live audience of clinical and research faculty and trainees. New clinical and research findings will be presented on topics in several broad areas, including new management strategies in hypertension, advanced CKD, and ESKD, new targets and therapies in the management of glomerular and other progressive kidney diseases, and the impacts of new therapeutics and biologics on onco-nephrology and kidney transplantation.

1. •Discuss the roles of new drug therapies in the management of hypertension, hyperphosphatemia, and anemia in CKD and compare them with more established therapies.
2. Compare the differences, strengths, and weaknesses among newly emerging therapies for IgA nephropathy.
3. Outline new diagnostic and therapeutic options in the management of membranous nephropathy.
4. Summarize newly emerging therapeutic options and targets for the treatment of lupus nephritis and C3 glomerulopathy.
5. Identify and assess new therapies and mechanisms of APOL1-mediated chronic kidney disease.
6. Recognize the renal side effects associated with newer targeted cancer therapies.
7. Analyze treatment strategies for antibody-mediated kidney transplant rejection and recurrence of primary disease in kidney transplant patients.

The Keck School of Medicine of the University of Southern California designates this Live Activity activity for a maximum of 6.75 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Cancellation Policy
Cancellations must be received by the USC Office of CME by email only by _________ at 12:00pm PDT for a refund. A $50 cancellation fee will be applied. In the event of course cancellation by conference organizers, all registration fees will be fully refunded. USC will not refund any travel costs incurred.


Accessibility Statement
 
Keck School of Medicine Healthcare System is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008. If you have needs that require special accommodations, including dietary concerns, please contact the USC Office of CME at [email protected].

The Keck School of Medicine Healthcare System School of Medicine adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Keck School of Medicine Continuing Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Friday, June 6, 2025